An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung
Clinical trial NCT03371381 · TERMINATED
Trial details
- NCT number
- NCT03371381
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2018-10-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.